Perlecan and the blood-brain barrier: Beneficial proteolysis?

Frontiers in Pharmacology

Volumn 3 AUG, Issue , 2012, Pages

  Roberts, Jill ^a   Kahle, Michael P ^a,b   Bix, Gregory J ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Blood brain barrier; Brain; Domain V; Extracellular matrix; Perlecan; Stroke; Vascular basement membrane

Indexed keywords

PERLECAN;

ANGIOGENESIS; ARTICLE; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CARBOXY TERMINAL SEQUENCE; CEREBROVASCULAR ACCIDENT; EXTRACELLULAR MATRIX; HUMAN; NEUROPROTECTION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION;

EID: 84866148470     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00155     Document Type: Article

References (36)

1. Ahsan, M. S., Yamazaki, M., Maruyama, S., Kobayashi, T., Ida-Yonemochi, H., Hasegawa, M., Henry Ademola, A., Cheng, J., and Saku, T. (2011). Differential expression of perlecan receptors, alpha-dystroglycan and integrin beta1, before and after invasion of oral squamous cell carcinoma. J. Oral Pathol. Med. 40, 552-559.
2. Al-Ahmad, A. J., Lee, B., Saini, M., and Bix, G. J. (2011). Perlecan domain V modulates astrogliosis in vitro and after focal cerebral ischemia through multiple receptors and increased nerve growth factor release. Glia 59, 1822-1840.
3. Arikawa-Hirasawa, E., Watanabe, H., Takami, H., Hassell, J. R., and Yamada, Y. (1999). Perlecan is essential for cartilage and cephalic development. Nat. Genet. 23, 354-358.
4. Baeten, K. M., and Akassoglou, K. (2011). Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke. Dev. Neurobiol. 71, 1018-1039.
5. Bix, G., Fu, J., Gonzalez, E. M., Macro, L., Barker, A., Campbell, S., Zutter, M. M., Santoro, S. A., Kim, J. K., Hook, M., Reed, C. C., and Iozzo, R. V. (2004). Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin. J. Cell Biol. 166, 97-109.
6. Bix, G., and Iozzo, R. V. (2008). Novel interactions of perlecan: unraveling perlecan's role in angiogenesis. Microsc. Res. Tech. 71, 339-348.
7. Bolton, S. J., Anthony, D. C., and Perry, V. H. (1998). Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience 86, 1245-1257.
8. Costell, M., Gustafsson, E., Aszodi, A., Morgelin, M., Bloch, W., Hunziker, E., Addicks, K., Timpl, R., and Fassler, R. (1999). Perlecan maintains the integrity of cartilage and some basement membranes. J. Cell Biol. 147, 1109-1122.
9. D'Aversa, T. G., Eugenin, E. A., Lopez, L., and Berman, J. W. (2012). Myelin basic protein induces inflammatory mediators from primary human endothe-lial cells and blood-brain-barrier disruption: implications for the pathogenesis of multiple sclerosis. Neuropathol. Appl. Neurobiol. doi: 10.1111/j.1365-2990.2012.01279.x
10. Deguchi, Y., Okutsu, H., Okura, T., Yamada, S., Kimura, R., Yuge, T., Furukawa, A., Morimoto, K., Tachikawa, M., Ohtsuki, S., Hosoya, K., and Terasaki, T. (2002). Inter-nalization of basic fibroblast growth factor at the mouse blood-brain barrier involves perlecan, a heparan sul-fate proteoglycan. J. Neurochem. 83, 381-389.
11. del Zoppo, G. J., and Milner, R. (2006). Integrin-matrix interactions in the cerebral microvasculature. Arterioscler. Thromb. Vasc. Biol. 26, 1966-1975.
12. Dore-Duffy, P. (2008). Pericytes: pluripotent cells of the blood brain barrier. Curr. Pharm. Des. 14, 1581-1593.
13. Farach-Carson, M.C., and Carson, D. D. (2007). Perlecan - a multifunctional extracellular proteoglycan scaffold. Glycobiology 17, 897-905.
14. Folkman, J., and Shing, Y. (1992). Angiogenesis. J. Biol. Chem. 267, 10931-10934.
15. Ford-Perriss, M., Turner, K., Guimond, S., Apedaile, A., Haubeck, H. D., Turnbull, J., and Murphy, M. (2003). Localisation of specific heparan sul-fate proteoglycans during the prolif-erative phase of brain development. Dev. Dyn. 227, 170-184.
16. Fukuda, S., Fini, C. A., Mabuchi, T., Koziol, J. A., Eggleston, L. L. Jr., and Del Zoppo, G. J. (2004). Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke 35, 998-1004.
17. George, E. L., Georges-Labouesse, E. N., Patel-King, R. S., Rayburn, H., and Hynes, R. O. (1993). Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 119, 1079-1091.
18. Giros, A., Morante, J., Gil-Sanz, C., Fairen, A., and Costell, M. (2007). Perlecan controls neurogenesis in the developing telencephalon. BMC Dev. Biol. 7, 29.
19. Gonzalez, E. M., Reed, C. C., Bix, G., Fu, J., Zhang, Y., Gopalakrishnan, B., Greenspan, D. S., and Iozzo, R. V. (2005). BMP-1/Tolloid-like met-alloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan. J. Biol. Chem. 280, 7080-7087.
20. Handler, M., Yurchenco, P. D., and Iozzo, R. V. (1997). Developmental expression of perlecan during murine embryogenesis. Dev. Dyn. 210, 130-145.
21. Huber,J. D., Egleton, R. D., and Davis, T. P. (2001). Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 24, 719-725.
22. Kamouchi, M., Ago, T., Kuroda, J., and Kitazono, T. (2012). The possible roles of brain pericytes in brain ischemia and stroke. Cell. Mol. Neu-robiol. 32, 159-165.
23. Lee, B., Clarke, D., Al Ahmad, A., Kahle, M., Parham, C., Auckland, L., Shaw, C., Fidanboylu, M., Orr, A. W., Ogunshola, O., Fertala, A., Thomas, S. A., and Bix, G. J. (2011). Perlecan domain V is neuropro-tective and proangiogenic following ischemic stroke in rodents. J. Clin. Invest. 121, 3005-3023.
24. Milner, R., Hung, S., Erokwu, B., Dore-Duffy, P., Lamanna, J. C., and Del Zoppo, G. J. (2008). Increased expression of fibronectin and the alpha 5 beta 1 integrin in angiogenic cerebral blood vessels of mice subject to hypobaric hypoxia. Mol. Cell. Neurosci. 38, 43-52.
25. Milner, R., Hung, S., Wang, X., Berg, G. I., Spatz, M., and Del Zoppo, G. J. (2008). Responses of endothelial cell and astrocyte matrix-integrin receptors to ischemia mimic those observed in the neurovascular unit. Stroke 39, 191-197.
26. Poschl, E., Schlotzer-Schrehardt, U., Brachvogel, B., Saito, K., Ninomiya, Y., and Mayer, U. (2004). Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development 131, 1619-1628.
27. Saini, M. G., and Bix, G. J. (2012). Oxygen-glucose deprivation (OGD) and interleukin-1 (IL-1) differentially modulate cathepsin B/L mediated generation of neuroprotective perlecan LG3 by neurons. Brain Res. 1438, 65-74.
28. Saini, M. G., Pinteaux, E., Lee, B., and Bix, G. J. (2011). Oxygen-glucose deprivation and interleukin-1alpha trigger the release of perlecan LG3 by cells of neurovascular unit. J. Neurochem. 119, 760-771.
29. Whitelock, J. M., Melrose, J., and Iozzo, R. V. (2008). Diverse cell signaling events modulated by perlecan. Biochemistry 47, 11174-11183.
30. Willis, C. L., Nolan, C. C., Reith, S. N., Lister, T., Prior, M. J., Guerin, C. J., Mavroudis, G., and Ray, D. E. (2004). Focal astrocyte loss is followed by microvascular damage, with subsequent repair of the blood-brain barrier in the apparent absence of direct astrocytic contact. Glia 45, 325-337.
31. Wolburg, H., and Lippoldt, A. (2002). Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul. Pharmacol. 38, 323-337.
32. Wright, S., Parham, C., Lee, B., Clarke, D., Auckland, L., Johnston, J., Lawrence, A. L., Dickeson, S. K., Santoro, S. A., Griswold-Prenner, I., and Bix, G. (2012). Perlecan domain V inhibits alpha2 integrin-mediated amyloid-beta neurotoxicity. Neurobiol. Aging 33, 1379-1388.
33. Yang, Y., and Rosenberg, G. A. (2011). Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42, 3323-3328.
34. Yurchenco, P. D., and Patton, B. L. (2009). Developmental and pathogenic mechanisms of basement membrane assembly. Curr. Pharm. Des. 15, 1277-1294.
35. Yurchenco, P. D., and Schittny, J. C. (1990). Molecular architecture of basement membranes. FASEB J. 4, 1577-1590.
36. Zlokovic, B. V. (2008). The blood-brain barrier in health and chronic neu-rodegenerative disorders. Neuron 57, 178-201.